Alberta regulator sides with Aurora in Curaleaf hostile bid fight

Curaleaf, a consumer and medical cannabis provider, is pursuing a hostile bid for Canada's Aurora Cannabis. The Alberta Securities Commission dismissed Curaleaf's application to halt Aurora's at-the-market share program; Aurora's board unanimously recommends shareholders reject the revised bid, while Curaleaf says its offer represents an 86% premium.

Why it matters: The ruling is a win for Aurora's defense, though Curaleaf says its now 86% premium offer still stands.